For a long time the company focussed on one vertical for the technology and paid the price. I had it for a bit but sold out when they had to regroup. Then they started looking for ways to use the tech in less regulated and less automated spaces. I have been building a position again as the wine and pet products have gained momentum. The new CEO is much more commercially oriented and that is starting to show. They have not forgotten the medical applications but are realistic about faster modes to profitability in the meantime. Happy to keep building in the quiet spaces.
